[A case of drug-induced XXXX associated with chemotherapy (FOLFOX6, FOLFIRI, Bevacizumab) for an advanced @entity694 ].

@entity1 @entity2600 @entity651 @entity281 @entity12024 @entity134 @entity764 @entity1576 @entity694
A @entity1 in her late sixties had an operation for ascending @entity694 15 months before her current admission. The pathological finding was T3(mod. SE), @entity12024 , M0, Stage IV. She had received chemotherapy after her operation. The first-line therapy comprised 15 courses of FOLFOX6 (from 14 to 5 months before admission). Her second-line chemotherapy comprised 6 courses of FOLFOX6+bevacizumab (BV) (from 3 to 2 months before admission). The third-line chemotherapy comprised 3 courses of FOLFIRI+BV (from 40 to 11 days before admission). She developed a high fever and @entity1576 3 days before admission. On admission to our hospital, her chest X-ray and CT showed ground-grass opacities in bilateral lung fields. Bronchoalveolar lavage showed a predominance of lymphocytes without any evidence of @entity281 . We diagnosed the @entity1 as a case of @entity651 caused by anticancer drugs. @entity134 therapy was implemented, and her fever, @entity1576 , and @entity764 disappeared. @entity134 therapy was stopped 6 months later and subsequently @entity651 did not recur. Judging by the progress seen in this case, we concluded that her @entity651 was due to @entity2600 . We continued the chemotherapy for her @entity694 by prescribing S-1, it proved ineffective. The @entity1 died from the @entity694 27 months after her operation.
